SCALABLE MANUFACTURING OF CAR-T CELLS USING A NON -VIRAL APPROACH AND A TRANSPOSON-TRANSPOSASE SYSTEM

被引：0
|
作者：
Couto, P. Silva [1 ]
Stibbs, D. [1 ]
Springuel, P. [2 ]
Rafiq, Q. A. [3 ]
机构：
[1] UCL, Biochem Engn, London, England
[2] UCL, Dept Biochem Engn, London, England
[3] UCL, Dept Biochem Engn, London, England
来源：
CYTOTHERAPY | 2024年 / 26卷 / 06期
关键词：
CAR-T; manufacturing; electroporation;
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
1002
引用
收藏
页码：S196 / S196
页数：1
相关论文
共 50 条
  • [31] PRGN-3005 UltraCAR-T™: multigenic CAR-T cells generated using non-viral gene delivery and rapid manufacturing process for the treatment of ovarian cancer
    Chan, Tim
    Chakiath, Marion
    Shepard, Lindsey
    Metenou, Simon
    Carvajal-Borda, Fernando
    Velez, Jose
    Govekung, Adeline
    Plummer, Jacques
    Poortman, Carol
    Kamineny, Padma
    Ma, Xiaohong
    Shah, Rutul R.
    Disis, Mary L.
    Sabzevari, Helen
    CANCER RESEARCH, 2020, 80 (16)
  • [32] Non-Viral Engineered CAR-T Cells for Safe and Specific Stem Cell Transplant Conditioning
    Timberlake, Nina D.
    Koechlein, Claire S.
    Richter, Maximilian
    Wang, Xinxin
    Chen, Natalie
    Cam, Nicholas
    Codde, Rebecca
    Tan, Yening
    Avanesyan, Armenuhi
    Hermann, Kip
    Ostertag, Eric M.
    Shedlock, Devon J.
    Down, Julian
    MOLECULAR THERAPY, 2018, 26 (05) : 236 - 237
  • [33] The paths toward non-viral CAR-T cell manufacturing: A comprehensive review of state-of-the-art methods
    Metanat, Yekta
    Viktor, Patrik
    Amajd, Ayesha
    Kaur, Irwanjot
    Hamed, Ashraf Mohammed
    Al-Abadi, Noor K. Abed
    Alwan, Nathera Hussin
    Chaitanya, M. V. N. L.
    Lakshmaiya, Natrayan
    Ghildiyal, Pallavi
    Khalaf, Othman Mahjoob
    Ciongradi, Carmen Iulia
    Sarbu, Ioan
    LIFE SCIENCES, 2024, 348
  • [34] Emerging therapies using CAR-T cells in lymphoma
    Salles, Gilles
    Sesques, Pierre
    Ferrant, Emmanuelle
    Safar, Violaine
    Ghesquieres, Herve
    Bachy, Emmanuel
    BULLETIN DU CANCER, 2018, 105 : S168 - S177
  • [35] Establishing a scalable perfusion strategy for the manufacture of CAR-T cells in stirred-tank bioreactors using a quality-by-design approach
    Hood, Tiffany
    Springuel, Pierre
    Slingsby, Fern
    Sandner, Viktor
    Geis, Winfried
    Schmidberger, Timo
    Bevan, Nicola
    Vicard, Quentin
    Hengst, Julia
    Dianat, Noushin
    Rafiq, Qasim A.
    BIOENGINEERING & TRANSLATIONAL MEDICINE, 2025,
  • [36] Manufacturing NKG2D CAR-T cells with piggyBac transposon vectors and K562 artificial antigen-presenting cells
    Tay, Johan C. K.
    Wang, Junjian
    Du, Zhicheng
    Ng, Yu Yang
    Li, Zhendong
    Ren, Yuefang
    Zhang, Chang
    Zhu, Jianqing
    Xu, Xue Hu
    Wang, Shu
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2021, 21 : 107 - 120
  • [37] Precise, Non-Viral, CAR-T Engineering with CRISPR sgRNA and ssDNA
    Ye, Lumeng
    MOLECULAR THERAPY, 2020, 28 (04) : 460 - 461
  • [38] A Novel Approach to Manufacture CAR-T Cells for Clinical Applications
    Bajgain, Pradip
    Mucharla, Roopa
    Anurathapan, Usanarat
    Lapteva, Natalia
    Leen, Ann M.
    Heslop, Helen E.
    Rooney, Cliona M.
    Vera, Juan F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S194 - S195
  • [39] Memory-rich CAR-T cell engineering by piggyBac transposon system for solid malignancies
    Yagyu, Shigeki
    CANCER SCIENCE, 2023, 114 : 1589 - 1589
  • [40] CAR-T cells management in french hospitals: manufacturing, distribution, and regulatory aspects
    Chabannon, Christian
    Larghero, Jerome
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2018, 202 (07): : 1431 - 1439
12345